This page is kept for reference and is not offered to search engines.
Indication
PreHevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis B virus in adults. It can be expected that hepatitis D will also be prevented by immunisation with PreHevbri as hepatitis D (caused by the delta agent) does not occur in the absence of hepatitis B infection. The use of PreHevbri should be in accordance with official recommendations.
In other countries
The same active substances on other registers, the same brand first.
- Lgvac-B Hepatitis B VaccineTaiwan · 注射劑 · 保生製藥股份有限公司科學園區分公司Same form
- Engerix-BCanada · 20 MCG / 1 ML · Suspension · Glaxosmithkline INCSame substance
- Engerix-BCanada · 10 MCG / 0.5 ML · Suspension · Glaxosmithkline INCSame substance
- Recombivax HBCanada · 40 MCG / ML · Suspension · Merck Canada INCSame substance